timeline image 2023

2023

timeline image 2023

Second own-developed product launch | Five new dossiers finalized | New supply division implemented

timeline image 2022

2022

timeline image 2022

Four new ODP dossier development completed | 170 employees

timeline image 2021

2021

timeline image 2021

First launch of own-developed (OD) product at patent expiry | Fourth OD dossier development completed | Full commercial structure in place | National acknowledgement of outstanding performance and substantial growth | EUR16.3m funding secured from Icelandic investor community | 130 employees

timeline image 2020

2020

timeline image 2020

Leadership structure finalised | Third own-developed (OD) dossier development completed | First submissions of OD product dossiers to European health authorities

timeline image 2019

2019

timeline image 2019

Acquisition of R&D operations and facilities from Teva, including 35 expert personnel | First delivery of a contract manufactured product

timeline image 2018

2018

timeline image 2018

Coripharma founded | Acquisition of Actavis ehf. in Iceland from Teva, including manufacturing facilities, equipment and quality systems

Powerful heritage

2016

Actavis acquired by Teva Pharmaceuticals, as part of its global acquisition of Allergan’s generics business

2012

Actavis acquired by Watson Pharmaceuticals (later Allergan) and merged entity retains the name Actavis

1998 - 2009

Facility expanded twice, increasing capacity | Delta hf. merges with Icelandic company Pharmaco, then rebranded as Actavis in 2004

1981

Icelandic pharmaceutical company Delta hf. establishes manufacturing facility to focus primarily on domestic production